Xinyuan Lu

3.2k total citations
47 papers, 1.3k citations indexed

About

Xinyuan Lu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xinyuan Lu has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Xinyuan Lu's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and MicroRNA in disease regulation (5 papers). Xinyuan Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and MicroRNA in disease regulation (5 papers). Xinyuan Lu collaborates with scholars based in China, United States and Hong Kong. Xinyuan Lu's co-authors include Wen‐Ming Cong, Wendell G. Yarbrough, Hui Dong, Feng Shen, W. Y. Lau, Xianghuo He, Mengchao Wu, Lei Chen, Guang‐Zhi Jin and Eric A. Collisson and has published in prestigious journals such as Genes & Development, PLoS ONE and Hepatology.

In The Last Decade

Xinyuan Lu

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyuan Lu China 19 659 455 321 291 233 47 1.3k
Abdirashid M. Shire United States 16 537 0.8× 157 0.3× 161 0.5× 131 0.5× 227 1.0× 26 1.0k
Hongping Yu China 18 629 1.0× 325 0.7× 258 0.8× 80 0.3× 94 0.4× 58 990
Michael F. Daily United States 17 340 0.5× 137 0.3× 244 0.8× 268 0.9× 347 1.5× 34 947
Ling Deng China 15 1.2k 1.8× 972 2.1× 294 0.9× 49 0.2× 93 0.4× 47 1.6k
Catherine Daly United Kingdom 16 457 0.7× 268 0.6× 795 2.5× 158 0.5× 169 0.7× 35 1.3k
Weijuan Jia China 19 235 0.4× 439 1.0× 522 1.6× 45 0.2× 140 0.6× 34 1.0k
A. Scott Pearson United States 16 217 0.3× 122 0.3× 283 0.9× 229 0.8× 223 1.0× 33 878
Giovanni Benedetti Italy 15 314 0.5× 148 0.3× 1.1k 3.3× 444 1.5× 244 1.0× 20 1.5k
Shuangfeng Chen China 15 308 0.5× 156 0.3× 175 0.5× 76 0.3× 90 0.4× 56 833

Countries citing papers authored by Xinyuan Lu

Since Specialization
Citations

This map shows the geographic impact of Xinyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyuan Lu more than expected).

Fields of papers citing papers by Xinyuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyuan Lu. The network helps show where Xinyuan Lu may publish in the future.

Co-authorship network of co-authors of Xinyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyuan Lu. A scholar is included among the top collaborators of Xinyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyuan Lu. Xinyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Xinyuan, et al.. (2025). Analysis of Adherence Status and Influencing Factors Among Middle‐Aged and Elderly Hypertension Patients in Rural Areas of Northeast China. International Journal of Hypertension. 2025(1). 9954099–9954099. 1 indexed citations
2.
Lu, Xinyuan, et al.. (2025). Effect of Comprehensive Health Management on Medication Adherence and Healthy Lifestyle Behavior of Patients With Hypertension. International Journal of Hypertension. 2025(1). 1165809–1165809.
3.
Yang, Ping, Xiaoliang Yang, Xianghua Zhang, et al.. (2023). The association of carbohydrate antigen 19‐9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study. Cancer. 129(19). 2999–3009. 1 indexed citations
4.
Lu, Xinyuan, et al.. (2021). The association between physical activity, sedentary time and health-related quality of life in cancer survivors. Health and Quality of Life Outcomes. 19(1). 213–213. 6 indexed citations
5.
Lu, Yao, et al.. (2021). Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles. Frontiers in Physiology. 12. 576917–576917. 8 indexed citations
6.
7.
Zhu, Yanjing, Bo Zheng, Guijuan Luo, et al.. (2019). Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics. 9(12). 3526–3540. 202 indexed citations
8.
Zhang, Xianghua, Lei Huo, Caifeng Liu, et al.. (2019). Arterial hyperenhancement of small intrahepatic cholangiocarcinomas correlates with microvessel counts and patient survival. HPB. 22(8). 1197–1205. 1 indexed citations
9.
Lu, Xinyuan, Di Chen, Jie Ding, et al.. (2018). Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma. Frontiers in Pharmacology. 8. 973–973. 25 indexed citations
10.
Chen, Zhiao, Xinyuan Lu, Deshui Jia, et al.. (2018). Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression. Cell Death and Disease. 9(2). 59–59. 30 indexed citations
11.
Lu, Xinyuan, Nir Peled, John J. Greer, et al.. (2017). MET Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma. Cancer Research. 77(16). 4498–4505. 49 indexed citations
12.
Li, Xiaofeng, Cheng Chen, Daimin Xiang, et al.. (2017). Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology. 66(6). 1934–1951. 104 indexed citations
13.
14.
Liu, Haiping, Qian Zhao, Guang‐Zhi Jin, et al.. (2015). Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population. Pathology - Research and Practice. 211(12). 918–924. 8 indexed citations
15.
Roy, Nilotpal, Shivani Malik, Atsushi Urano, et al.. (2015). Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes & Development. 29(6). 658–671. 106 indexed citations
16.
Wang, Bin, Chunyan Xia, W. Y. Lau, et al.. (2013). Determination of Clonal Origin of Recurrent Hepatocellular Carcinoma for Personalized Therapy and Outcomes Evaluation: A New Strategy for Hepatic Surgery. Journal of the American College of Surgeons. 217(6). 1054–1062. 49 indexed citations
17.
Xian, Zhi‐Hong, Wen‐Ming Cong, Xinyuan Lu, Hua Yu, & Mengchao Wu. (2011). Angiogenesis and lymphangiogenesis in sporadic hepatic angiomyolipoma. Pathology - Research and Practice. 207(7). 403–409. 4 indexed citations
18.
Lu, Xinyuan, Tao Xi, W. Y. Lau, et al.. (2011). Hepatocellular Carcinoma Expressing Cholangiocyte Phenotype Is a Novel Subtype with Highly Aggressive Behavior. Annals of Surgical Oncology. 18(8). 2210–2217. 54 indexed citations
19.
Lu, Xinyuan, Tao Xi, W. Y. Lau, et al.. (2010). Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. Journal of Cancer Research and Clinical Oncology. 137(4). 567–575. 72 indexed citations
20.
Zhao, Qian, Changqing Su, Hui Dong, et al.. (2010). Hepatocellular Carcinoma and Hepatic Adenocarcinosarcoma in a Patient with Hepatitis B Virus-Related Cirrhosis. Seminars in Liver Disease. 30(1). 107–112. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdirashid M. Shire Breakdown of academic impact, for papers by Hongping Yu Breakdown of academic impact, for papers by Michael F. Daily Breakdown of academic impact, for papers by Ling Deng Breakdown of academic impact, for papers by Catherine Daly Breakdown of academic impact, for papers by Weijuan Jia Breakdown of academic impact, for papers by A. Scott Pearson Breakdown of academic impact, for papers by Giovanni Benedetti Breakdown of academic impact, for papers by Shuangfeng Chen
Rankless by CCL
2026